Campbell’s Sold You “Microwavable” Soup That Pumps Microplastic Directly Into Your Food

The Non-Financial Ledger

Picture the scenario this product was built for. It is a Tuesday at noon. A parent heats up a Campbell’s Chicken Noodle Soup bowl for a kid who just got home from school. They peel back the lid, drop it in the microwave, press two minutes, and walk away. That is exactly what the label told them to do. That is the entire product promise. Convenient. Safe. Microwavable. The word is right there on the packaging in plain English.

What the label does not say is that those two minutes in the microwave are filling the soup with hundreds of thousands of plastic particles that will pass through the child’s gut, alter the bacteria living there, and begin accumulating in tissues throughout the body. Not just once. Every time. Because the soup is designed for repeated, near-daily use, and because microplastics bioaccumulate, each bowl compounds the last.

The people who buy these products are not naive. They read labels. They trust labels. They trust Campbell’s specifically because it has spent over a century building that trust. The red-and-white can is not just a product; it is a cultural shorthand for comfort food, for a brand that belongs in your kitchen, that you give your children without a second thought. Campbell’s leveraged every gram of that trust to sell a product it knew released plastic into food.

Parents trying to reduce their children’s exposure to harmful chemicals have no way to identify the danger from the packaging. Average consumers are not experts in polypropylene chemistry. They cannot look at a plastic lid and assess its microplastic release profile at 90 degrees Celsius. They relied on the manufacturer to do that job for them. That is what the word “Microwavable” on a product label is supposed to mean: we checked, and it is safe. Campbell’s said exactly that while concealing the opposite.

The harm here is not hypothetical future risk communicated in the abstract. Research published in the New England Journal of Medicine found that patients with carotid artery plaque containing microplastics had a measurably higher risk of heart attack, stroke, or death from any cause at 34 months of follow-up. A 2025 study in Nature Medicine found microplastic concentrations in human brains are 7 to 30 times higher than in livers or kidneys, with dementia cases showing even greater concentrations. Brain samples collected in 2024 showed 50% higher microplastic levels than samples from 2016. The contamination is escalating. The families who heated Campbell’s soup multiple times a week contributed to their own body burden while following the manufacturer’s explicit instructions.

Legal Receipts

The complaint filed in the Northern District of California on April 10, 2026 documents the core accusations in the plaintiffs’ own words, sourced directly from the court filing.

“Research shows that microwave heating causes the highest release of microplastics and nanoplastics into food compared to other usage scenarios, such as refrigeration or room-temperature storage. It was found that some packaging made with polypropylene could release as many as 4.22 million microplastic and 2.11 billion nanoplastic particles from only one square centimeter of plastic area within 3 minutes of microwave heating.”

• This establishes that the danger is not incidental; microwave use is specifically the worst condition for plastic particle release. Campbell’s markets these products for exactly this use and calls it safe.
• The figure of 4.22 million microplastics and 2.11 billion nanoplastic particles from one square centimeter in three minutes comes from a peer-reviewed study cited in the complaint (Hussain et al., ACS Publications, 2023). This is not activist science; it is published, peer-reviewed research Campbell’s had access to.

“Researchers found that multiple short heating cycles are actually worse than one long one; for instance, three 20-second sessions released 132% more plastic than a single 60-second session.”

• This is critical because “short bursts” are the common microwave behavior for reheating soup. The product’s everyday use pattern is the highest-release scenario documented by the science.
• The fact that this information existed in the research literature and was still absent from the product label is central to the deception claim.

“Defendant knew or should have known that the affirmative ‘Microwavable’ misrepresentations and material omission would lead reasonable consumers into believing that the Products would be safe, as promised, for microwaving soup rather than expose them or their families to harmful microplastics. Not only has Defendant utilized a long-standing brand strategy to promote its Products as safe and reliable for common household use, but Defendant also has an obligation under Section 5 of the Federal Trade Commission Act, codified at 15 U.S.C. § 45, to evaluate its marketing claims from the perspective of the reasonable consumer.”

• This is the complaint establishing that Campbell’s had a statutory duty under federal law to evaluate whether “Microwavable” would mislead a reasonable consumer. The complaint argues they either violated that duty or chose not to perform it because the findings would have forced them to change the label.
• This framing converts the case from a simple mislabeling claim into a documented failure of a legally required compliance process.

“Defendant knew that disclosing the risk of microplastic leaching would likely deter consumers from purchasing the Products and so it unlawfully elected instead to falsely promise they are microwavable.”

• The complaint alleges this was a calculated commercial decision: Campbell’s weighed consumer retention against consumer health and chose revenue.
• A study cited in the complaint (Nagy et al., Nature, 2024) found that consumers place substantial value on labels that warn about microplastic risk, and that disclosure would affect purchasing decisions. The implication: Campbell’s had market research confirming disclosure would cost them sales, making the omission a deliberate business strategy.

Public Deception: What the Label Said vs. What Was Happening

The complaint documents a direct, documented gap between Campbell’s public-facing representations and what the company’s own packaging was doing to the food inside.

• Campbell’s labeled dozens of soup products “Microwavable” across all product lines, sizes, and SKUs. This representation was placed prominently on the front label of every product. The word communicates a safety guarantee to a reasonable consumer: this product is designed and verified safe for microwave use.
• The reality documented in the complaint: the lids and packaging are made of polypropylene plastic, which releases harmful microplastic and nanoplastic particles directly into the soup when microwaved. The products cannot deliver the core attribute the label promises.
• Campbell’s advertised the products on its official website as designed for microwave use, reinforcing the front-label claim across multiple consumer touchpoints. The omission of any microplastic risk disclosure was consistent across packaging, advertising, and the company’s web presence.
• No disclaimer, qualifier, or warning appeared anywhere on the product packaging disclosing that microwaving the product would cause it to leach plastic into the food. Plaintiff Garvey specifically confirmed she observed no such disclosure at the time of her June 2025 Amazon purchase.
• A study cited in the complaint (Nagy et al., Nature, 2024) found that consumers value labels that warn about microplastic risk and that disclosure would affect purchasing decisions. The complaint alleges Campbell’s knew this and chose omission because disclosure would cost them sales.

Profit-Maximization at All Costs

The complaint documents a commercial calculation at the center of this case: Campbell’s knew the “Microwavable” label was false and that disclosure would reduce sales, and chose the label anyway.

• A study cited in the complaint (Nagy et al., Nature, August 2024) tested consumer willingness to pay for products with and without microplastic risk disclosures. The results showed consumers place substantial value on labels that warn about microplastic harm. The complaint draws a direct line: Campbell’s was aware that disclosure would affect purchasing decisions and withheld that disclosure to protect revenue.
• The complaint characterizes Campbell’s as “a major player in the industry employing teams of people for whom product safety and testing should be a chief concern,” establishing that the company had the resources and institutional capacity to know about microplastic risks and test for them. The failure to disclose is framed as a deliberate choice, not ignorance.
• By marketing the products as “Microwavable” without disclosing the microplastic risk, Campbell’s gained what the complaint calls “an unfair competitive advantage over those who do not falsely tout such use as safe.” Competitors who were honest about packaging limitations were undercut by a brand willing to make a safety claim it could not support.
• Plaintiff and class members paid a price premium for products marketed with safety attributes the products did not possess. The complaint seeks disgorgement of ill-gotten gains, restitution, and damages representing the premium consumers overpaid for a false promise.
• The amount in controversy exceeds $5,000,000 as stated in the complaint’s jurisdictional claims, with the nationwide class estimated to consist of tens of thousands of purchasers.

Societal Impact Mapping

Public Health

The documented health consequences of microplastic ingestion span multiple organ systems and are tied directly to the type of packaging Campbell’s used in products marketed for near-daily family consumption.

• Microplastics alter the composition of gut microbiota, disrupting digestion, nutrient absorption, and immune system development. The complaint cites a study published in Nature (Tamargo et al., 2022) confirming that microplastics are “capable of digestive-level health effects.”
• Studies cited in the complaint document that microplastics “produce a toxic effect on the digestive tract” and cause “irreversible changes in the reproductive axis and central nervous system of offspring after prenatal and neonatal exposure.” Products marketed to families with children created a direct exposure pathway for this harm.
• Microplastics have been found in human blood, saliva, liver, kidneys, and placenta, demonstrating their ability to move throughout the body. Nanoplastics have been documented entering cells and penetrating cell nuclei.
• A study published in the New England Journal of Medicine (Marfella et al., March 2024) found that patients with carotid artery plaque containing microplastics faced a higher risk of a composite of myocardial infarction, stroke, or death from any cause at 34 months of follow-up.
• A February 2025 study in Nature Medicine found that human brains accumulate microplastics at concentrations 7 to 30 times greater than liver or kidney tissue, and that dementia cases showed even greater concentrations. Brain samples from 2024 showed approximately 50% higher microplastic levels than samples from 2016.
• A September 2024 study found polypropylene microplastics — the same material used in Campbell’s packaging — in human bone marrow. A separate September 2024 study confirmed microplastics in the human brain, with authors warning that the results “should raise concern in the context of increasing prevalence of neurodegenerative diseases.”
• Microplastic ingestion has been linked to colon cancer, which is rising in young people, and other gastrointestinal cancers. People with liver damage show an 8-fold increase in plastic contamination compared to healthy individuals.
• Children face disproportionate risk. Scientists studying microplastics have emphasized that their impacts are especially dangerous for children and have called on governments and industries to take steps to avoid plastic contact with children’s meals.
• Microplastics bioaccumulate: every exposure compounds previous exposures. Products intended for near-daily household use create a recurring contamination pathway that increases in harm with each use.

Economic Inequality

Microwavable convenience foods are disproportionately purchased by working families who rely on fast, affordable meal solutions and who are least positioned to independently investigate packaging material safety.

• The complaint identifies families seeking “convenient, ‘microwavable’ meals for school, work, and travel” as the core demographic targeted by Campbell’s marketing. These are not high-income consumers buying premium health products; these are people who need speed and affordability in meal preparation.
• Average consumers are, as the complaint notes, “not sophisticated in the knowledge of plastic composition or in the manufacturing, composition, and formulation of microwavable soup products.” They have no independent means of detecting microplastic risk from a product label. They were entirely dependent on the manufacturer’s representation.
• Consumers paid a price premium for products marketed as safe for microwave use, a safety attribute the products did not possess. The economic harm is: they paid for a safety feature that was a lie.
• The class spans tens of thousands of consumers nationally, with individual damages that would be too small to justify individual litigation but collectively represent millions of dollars extracted from families who trusted a label.

The Settlement Isn’t Justice — Yet

No settlement has been reached in this case as of the filing date; the complaint was filed April 10, 2026 and the litigation is active. This section documents what the complaint is asking for and what structural accountability would require.

• The complaint seeks damages, restitution, and disgorgement of ill-gotten gains on behalf of the nationwide class and California subclass. It also seeks punitive damages where permitted by the causes of action alleged.
• Critically, the complaint also seeks injunctive relief: a court order requiring Campbell’s to either remove the “Microwavable” label from products that cannot deliver it safely, add conspicuous microplastic risk disclosures, modify the products to eliminate the danger, or stop selling them. Money alone would not stop the ongoing harm to future consumers.
• The complaint explicitly frames the case as requiring both compensation for past harm and structural change to prevent future harm. A settlement that delivers checks to class members without changing the label would leave the next million buyers in the same position as the plaintiffs.

The “Cost of a Life” Metric

This Is the System Working as Intended

The facts of this case do not describe a company that failed to notice a safety problem. They describe a company that had access to the science, calculated that disclosure would hurt sales, and chose to print “Microwavable” on the label anyway.

• Campbell’s had statutory obligations under the FTC Act to evaluate its marketing claims from the perspective of a reasonable consumer. The complaint documents this obligation explicitly. The company either performed that evaluation and knew the claim was false, or failed to perform the evaluation that the law required. Both paths lead to the same result.
• The science on polypropylene microplastic release under microwave heating was not obscure or newly published. The complaint cites studies from 2020, 2021, 2022, 2023, and 2024 that documented this exact risk profile. Industry forums and consumer safety reports had also covered it. Campbell’s, as a major food manufacturer with product safety teams, had access to all of it.
• The consumer protection laws designed to prevent exactly this conduct — California’s UCL, FAL, and CLRA — require class action litigation to enforce. There is no federal agency with a proactive enforcement program mandating microplastic disclosure on food packaging. Accountability requires a private plaintiff to bear the burden of suing a company with vastly greater legal resources.
• The complaint seeks injunctive relief precisely because money damages alone do not stop ongoing harm. Until a court orders Campbell’s to change the label or change the product, every consumer who buys a Campbell’s “Microwavable” bowl today is in the same position as every consumer before the lawsuit was filed.
• Campbell’s brand power amplified the harm. The complaint specifically notes that “Campbell’s Soup’s widespread recognition as a leading brand amplifies consumer trust in the safety of the Products.” The more trusted the brand, the more effective the false safety claim. Brand equity was the mechanism of deception.

What a Legitimate Fix Looks Like

Editorial analysis. The following recommendations are grounded in the specific failure modes documented in the complaint and are labeled as editorial judgment, not findings of the source document.

The core structural failure this case exposes: federal food safety law contains no requirement that manufacturers test for or disclose microplastic migration from packaging into food, even when that packaging is marketed for heating use. The “Microwavable” label carries no regulatory definition that includes a microplastic safety standard. Campbell’s was operating in a disclosure vacuum, and it exploited that vacuum.

• The FDA should establish mandatory microplastic migration testing standards for any food packaging marketed as suitable for microwave or high-heat use. A product cannot carry the word “Microwavable” without passing documented safety thresholds for plastic particle release at microwave temperatures.
• The FTC, which already holds the statutory authority cited in this complaint (15 U.S.C. § 45), should issue formal guidance clarifying that “Microwavable” is a safety representation, not just a compatibility statement. Any claim that a product is safe for microwave use must be substantiated by testing under FTC’s established substantiation standard.
• Consumer product safety reporting requirements should be extended to cover microplastic release rates in food-contact packaging, with results made publicly accessible so consumers, researchers, and competitors can evaluate claims independently.

• Congress should pass legislation requiring food-contact packaging manufacturers to disclose material composition — specifically the type of plastic used in lids and containers — and any documented microplastic or chemical migration risks associated with that material under standard use conditions including heating.
• California’s existing consumer protection framework (UCL, FAL, CLRA) is functioning as a backstop in this case, but its effectiveness depends on private litigants with the resources to file class actions. Federal legislation creating a private right of action for microplastic mislabeling would extend this protection to consumers in states without comparable laws.
• Legislation should require that any “Microwavable” claim on food packaging be accompanied by a standardized disclosure of the packaging material and its tested microplastic release profile, in plain language accessible to a general consumer.

• Campbell’s should be required, as part of any injunctive resolution of this case, to implement an independent product safety review process specifically covering packaging material safety under all advertised use conditions. That process should include microplastic migration testing and a documented decision trail showing how labeling claims were evaluated against test results.
• Executive compensation at Campbell’s should not be structured in a way that creates financial incentives to withhold safety information that would reduce sales. Any governance reform should include board-level oversight of product safety claims that carry legal representations to consumers.
• Campbell’s should reformulate the packaging to eliminate polypropylene in lids and containers used for microwave-marketed products, or immediately cease marketing those products as “Microwavable” until reformulation is complete and tested.